The role of clinical pharmacists in chronic disease management: Review

Abstract

Background: Chronic diseases, particularly non-communicable diseases (NCDs), are leading causes of morbidity and mortality globally. Effective management of these conditions, such as inflammatory bowel disease (IBD), requires a multidisciplinary approach, including the integration of clinical pharmacists into patient care teams. Methods: This review analyzed literature from seven databases, including MEDLINE and EMBASE, focusing on pharmacist interventions in the management of chronic diseases, specifically type 2 diabetes and asthma, to assess their applicability to IBD. Studies published between 2014 and 2023 were included to evaluate the impact of pharmacist-led initiatives on clinical outcomes. Results: The findings reveal that pharmacist interventions significantly improve patient outcomes in chronic disease management through medication management, patient education, and regular monitoring. While type 2 diabetes and asthma management strategies have been well-documented, there is a notable gap in research regarding pharmacist involvement in IBD care. Proposed interventions for IBD include medication adherence support, risk assessment, and preventive health services, which have demonstrated effectiveness in other chronic conditions. Conclusion: The integration of clinical pharmacists into the management of inflammatory bowel disease presents a valuable opportunity to enhance patient care.